Lemaitre Vascular (LMAT) Other financing activities (2014 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Other financing activities of $3.0 million for Q1 2026, up 125.0% year-over-year from $1.3 million in Q1 2025, and up 37.75% quarter-over-quarter from $2.1 million in Q4 2025.
Lemaitre Vascular (LMAT) Other financing activities (2014 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Other financing activities for 6 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 125.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $8.4 million (up 126.52% YoY), while the FY2025 annual figure was $6.8 million, up 6.25% from the prior year.
- Other financing activities improved to $3.0 million in Q1 2026 per LMAT's latest filing, from $2.1 million in the prior quarter.
- Across five years, Other financing activities topped out at $4.0 million in Q1 2024 and bottomed at $449000.0 in Q3 2024.
- Historically, Other financing activities has averaged $1.8 million across 5 years, with a median of $1.4 million in 2023.
- Annual changes were most pronounced in 2024 — Other financing activities slumped 79.87% — and 2025, when it surged 253.01%.
- Lemaitre Vascular's Other financing activities stood at $508000.0 in 2022, then soared by 121.85% to $1.1 million in 2023, then rose by 9.58% to $1.2 million in 2024, then jumped by 73.52% to $2.1 million in 2025, then jumped by 37.75% to $3.0 million in 2026.
- Business Quant data shows LMAT's Other financing activities at $3.0 million in Q1 2026, $2.1 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 776,000.00 |
| Jun 30, 2026 | 776,000.00 |
| Mar 31, 2026 | 2.95 Mn |
| Mar 31, 2026 | 2.95 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 1.76 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 449,000.00 |
| Sep 30, 2024 | 449,000.00 |
| Jun 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 730,000.00 |
| Mar 31, 2024 | 3.99 Mn |
| Mar 31, 2024 | 3.99 Mn |